Australia approves a new bird flu vaccine

Australian officials have approved a bid flu vaccine developed by CSL. And the government announced a $160 million budget to stockpile additional vaccines to help protect the country from an outbreak. The vaccine will only be used in the event of a pandemic.

Australian government officials appeared to be particularly pleased that they could stockpile a vaccine developed inside the country. According to CSL, Panvax can be adjusted to provide protection against any emerging pandemic. Experts note that the bird flu virus will need to mutate into a new strain in order to spread swiftly among people.

- read the story in the Herald-Sun

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.